SCHEMBL7327754

SCHEMBL7327754

Cc1oncc1C(=O)Nc1ccc(-n2nc(C(F)(F)F)cc2C(F)(F)F)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRACR2A Q9BSW2 8/20 0.74
ORAI1 Q96D31 3/20 0.64
TRPC3 Q13507 3/20 0.64
TRPC1 P48995 1/20 0.64
STIM1 Q13586 1/20 0.64
TP53 P04637 3/20 0.61
THRB P10828 2/20 0.61
NPC1 O15118 2/20 0.61
RAB9A P51151 2/20 0.61
GMNN O75496 1/20 0.61
LMNA P02545 1/20 0.61
CYP1A2 P05177 1/20 0.61
CYP3A4 P08684 1/20 0.61
HTR1A P08908 1/20 0.61
PIM1 P11309 1/20 0.61
CYP2C9 P11712 1/20 0.61
MAOA P21397 1/20 0.61
SLC6A2 P23975 1/20 0.61
HTR2A P28223 1/20 0.61
AGTR1 P30556 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1883639 0.85 CRACR2A (1.00) CRACR2AORAI1TP53THRBNPC1
SCHEMBL7234017 0.82 TP53 (0.86) CRACR2AORAI1TRPC3TRPC1STIM1
SCHEMBL7240068 0.81 CRACR2A (0.74) CRACR2AORAI1TRPC3TRPC1STIM1
SCHEMBL4120694 0.81 ORAI1 (0.64) CRACR2AORAI1TRPC3TRPC1STIM1
SCHEMBL7325947 0.81 ORAI1 (0.64) CRACR2AORAI1TRPC3TRPC1STIM1
SCHEMBL7328795 0.80 TP53 (0.69) CRACR2AORAI1TRPC3TRPC1STIM1
SCHEMBL7326340 0.79 ORAI1 (0.73) CRACR2AORAI1TRPC3TRPC1STIM1
SCHEMBL7325708 0.79 ORAI1 (0.79) CRACR2AORAI1TRPC3TRPC1STIM1
SCHEMBL7327208 0.78 ORAI1 (0.64) CRACR2AORAI1TRPC3TRPC1STIM1
SCHEMBL7319568 0.78 ORAI1 (0.64) CRACR2AORAI1TRPC3TRPC1STIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010044445-A1 AZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES 2001-11-22 US claimed
US-20010044445-A1 AZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES 2001-11-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010044445-A1 AZOLE INHIBITORS OF CYTOKINE PRODUCTION IL5, IL2, IL4 CRACR2A 3286/4885ORAI1 3522/4885TRPC3 4362/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.